A novel cost effective hematoxylin and eosin staining process for staining biological bone

IN605344BActive Publication Date: 2026-10-08SREE BALAJI MEDICAL COLLEGE & HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202141040748
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-09-08
Publication Date
2026-10-08
Estimated Expiration
2041-09-08

AI Technical Summary

Technical Problem

Current decalcifying agents used in histopathology often damage organic tissue components and adversely affect staining characteristics, necessitating a cost-effective and eco-friendly alternative for decalcifying bone samples.

Method used

A novel hematoxylin and eosin staining process employing apple vinegar as a decalcifying agent, combined with sequential steps involving deparaffinizing agents and staining procedures, to effectively remove calcium without harming tissue and enhance staining quality.

Benefits of technology

The process achieves superior staining properties, including intensity, softness, clarity, and crispness, while being safer, quicker, and more cost-effective compared to traditional hydrochloric acid methods, demonstrating vinegar's efficacy as a harmless and efficient decalcifying agent.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

APPLICANT: SREE BALAJI MEDICAL COLLEGE & HOSPITAL TITLE: A NOVEL COST EFFECTIVE HEMATOXYLIN AND EOSIN STAINING PROCESS FOR STAINING BIOLOGICAL BONE ABSTRACT The present invention discloses a novel, cost effective hematoxylin and eosin staining process for staining biological bone samples comprising cells, employing characterized decalcyfication agent. The process of the present invention comprises of the following sequential steps: (a) Characterized in that soaking the biological bone samples in vinegar at predetermined temperature for predetermined time for 70-80% removal of calcium (b) Contacting the biological bone samples of step(a) with deparaffinizing agent fresh Orange fruit extract I at predetermined temperature for predetermined time for removing 70% of impurities; (c) Contacting the biological bone samples of step(b) with deparaffinizing agent fresh Orange fruit extract II at predetermined temperature for predetermined time for removing remaining 30% of impurities; (d) Contacting the biological bone samples of step(c) with deparaffinizing agent fresh Orange fruit extract III at predetermined temperature for predetermined time for fixation and clarity of tissue in the said samples; (e) Dipping the biological bone samples of step(d) with acetone for decolourization followed by washing in tap water for predetermined time; (f) Staining the biological bone samples of step(e) with staining agent Haematoxylin for predetermined time for staining cytoplasm followed by washing in tap water for predetermined time; (g) Dipping the biological bone samples of step(f) with 1% acid alcohol for removing excess Haematoxylin followed by washing in tap water for predetermined time ; (h) Staining the biological bone samples of step(g) with staining agent Eosin for predetermined time for staining nucleus followed by washing in tap water for predetermined time; (i) washing the biological bone samples of step(h) with 50% alcohol for removing water; (j) washing the biological bone samples of step(i) with 70% alcohol for removing water; (k) washing the biological bone samples of step(j) with 100% alcohol for removing water and (l) drying the biological bone samples of step(k) and mounting to form stained biological sample with staining structures in cells.
Need to check novelty before this filing date? Find Prior Art

Description

The following specification particularly describes the invention and the manner in which it is to be performedFIELD OF THE INVENTION:The present invention relates to the field of Histopathology. More particularly the present invention relates to a novel, cost effective hematoxylin and eosin staining process for staining biological samples comprising cells, employing characterized decalcyfication agent.BACKGROUND OF THE INVENTION:In routine histopathology, decalcification of bone and teeth is often an essential and important step during tissue processing. Various decalcifying agents have been used in the past. The rate of decalcification and the effect of decalcifying agents on the tissue and its staining characteristics are two important parameters which influence the selection of decalcifying solutions. Though some agents remove the calcium ions completely and rapidly, they adversely affect the staining characteristics and may also damage the organic components. Thus there exists a need in the state of art to employ characterized decalcifying agent which does not affect the staining characteristics and damage the organic components.OBJECT OF THE INVENTION:The main object of the present invention is to develop a novel cost effective staining process for staining biological bonesamples comprising cells employing characterized decalcifying agent.Another object of the present invention is to utilize eco-friendly decalcifying agent, vinegar for decalcification Yet another object of the present invention is to compare the decalcifying characteristics of vinegar as decalcifying agent with HCl.Further object of the present invention is to employ the developed method for staining biological bone samples comprising cells. BRIEF DESCRIPTION OF DRAWINGS:Figure no 1 depicts the section from the bone shows adequate decalcification by apple vinegar. Section shows hyalineFigure no 2 depicts the high power view shows hyaline cartilage.Figure no 3 depicts the Section from the bone shows adequate decalcification by apple vinegar. Section shows lamellar bone with adipose tissue surrounded by acute inflammatory cells.Figure no 4 depicts the high power of bone shows lamellar bone with osteocytes in lacuna.SUMMARY OF THE INVENTION:The present invention discloses a novel, cost effective hematoxylin and eosin staining process for staining biological bone samples comprising cells, employing characterized decalcyfication agent. The process of the present invention comprises of the following sequential steps:a. Characterized in that soaking the biological bone samples in vinegar at predetermined temperature for predetermined time for 70-80% removal of calciumb. Contacting the biological bone samples of step(a) with deparaffinizing agent fresh Orange fruit extract I at predetermined temperature for predetermined time for removing 70% of impurities;c. Contacting the biological bone samples of step(b) with deparaffinizing agent fresh Orange fruit extract II at predetermined temperature for predetermined time for removing remaining 30% of impurities;d. Contacting the biological bone samples of step(c) with deparaffinizing agent fresh Orange fruit extract III at predetermined temperature for predetermined time for fixation and clarity of tissue in the said samples;e. Dipping the biological bone samples of step(d) with acetone for decolourization followed by washing in tap water for predetermined time;f. Staining the biological bone samples of step(e) with staining agent Haematoxylin for predetermined time for staining cytoplasm followed by washing in tap water for predetermined time;g. Dipping the biological bone samples of step(f) with 1% acid alcohol for removing excess Haematoxylin followed by washing in tap water for predetermined time ;h. Staining the biological bone samples of step(g) with staining agent Eosin for predetermined time for staining nucleus followed by washing in tap water for predetermined time;i. washing the biological bone samples of step(h) with 50% alcohol for removing water;j. washing the biological bone samples of step(i) with 70% alcohol for removing water;k. washing the biological bone samples of step(j) with 100% alcohol for removing water and l. drying the biological bone samples of step(k) and mounting to form stained biological sample with staining structures in cells.DETAILED DESCRIPTION OF THE INVENTION:The present invention discloses a novel, cost effective hematoxylin and eosin staining process for staining biological bone samples comprising cells, employing characterized decalcyfication agent.Vinegar by its solvent property makes the bone decalcify sooner and thin bony sections made in the slides, thus helping in decalcifying the sections.Procedure:Chemicals used:Sections from the bone specimen were taken from the amputated great toe specimen. Bone Sections were made into the block and sent for the Hematoxyline and eosin staining .In H&E staining two groups were separated Group A and Group B . Group A used vinegar as decalcifying agent and Group B as Hydrochloricacid as decalcifying agent.Steps of H&E staining with vinegar as decalcifying agent Group A 1. bone section taken from the amputated great toe specimens .2. bony section were immersed in vinegar for 3 days for decalcification3. thin section were made 3-4 micron and bone sections were subjected to staining4. Xylene-I for 10 minutes5. Xylene-II kept at 700 C for 10 minutes6. Xylene-III kept at 700 C for 10 miutes7. Acetone 1 dip8. Tap water wash 2 minutes9. Haematoxylin 10 minutes10. Tap water 2 minutes11. 1% acid alcohol 1- 2 dip12. Tap water wash 5 minutes13. Eosin 2 dip14. Tap water wash 2 wash 15. 50% alcohol16. 70% alcohol17. 100% alcohol 18. Dry and mountSteps of H&E staining with decalcifying agent in Group B1. bone section taken from the amputated great toe specimens .2. bony section were immersed in hydrochloric acid for 4 days for decalcification3. Thin section were made 3-4 micron and bone sections were subjected to staining4. Xylene-I for 10 minutes5. Xylene-II kept at 700 C for 10 minutes6. Xylene-III kept at 700 C for 10 miutes7. Acetone 1 dip8. Tap water wash 2 minutes9. Haematoxylin 10 minutes10. Tap water 2 minutes11. 1% acid alcohol 1- 2 dip12. Tap water wash 5 minutes13. Eosin 2 dip14. Tap water wash 2 wash 15. 50% alcohol16. 70% alcohol17. 100% alcohol 18. Dry and mountResult:Two sections of 3- 4 microns thickness were prepared. They were stained with hematoxylin and eosin stain ,considered in to 2 groups where vinegar (Group A), hydrochloric acid solution (Group B), were used as decalcifying agents. The stained sections are graded based on the parameters of intensity of bone softness, thin bone section in the slide ,Nuclear staining, Cytoplasmic staining, Clarity of staining, Uniformity of staining, Crispness of staining. The results showed that Group A had showed superior staining properties in all the parameters when compared to the hydrochloric acid. Being a Pathologist, it is essential to decrease the price and hazardous of unsafe chemical agents used in histopathological laboratories. The quality of eco-friendly decalcifying agents is more efficient than hydrochloric acid in H & E staining procedure. In addition to it, these are harmless, quicker and price effective. The concept of using vinegar as natural replacements to high concentrated hydrochloric acid is novel and inventive and a desirable step to the future acid free histopathological laboratories.Morphometric analysis: After reviewing, the sections were further subjected to morphometric analysis. The images were captured using microscope with a 100X objective. The final image captured on the monitor had a magnification of 1000X. For each specimen, intensity of bone softness, thin sections of bone ,distinct cellular and nuclear outlines were seen, avoiding overlapping to know the uniformity, clarity and crispiness of staining (Figure 1-4). Morphometric analysis of the H and E section of bone :Sl.no Features observed in the H and E bone slide Decalcification done by HCL Decalcification done by apple vinegar 1 intensity of bone 98% 99.4%2 softness, 70% 65%3 thin sections of bone 4 µm 3µm4 Distinct cellular and nuclear outlines 98% 99%5 uniformity, clarity and crispiness of staining 98.7% 99.4%From the figures it is inferred that decalfication by bone is easier , harmless , quiker and effective process when compared to the decalcification through hydrochloric acid In one of the preferred embodiment the present invention shall disclose a novel, cost effective hematoxylin and eosin staining process for staining biological bone samples comprising cells, employing characterized decalcyfication agent. The process of the present invention comprises of the following sequential steps:a. Characterized in that soaking the biological bone samples in apple vinegar at predetermined temperature for predetermined time for 70-80% removal of calciumb. Contacting the biological bone samples of step(a) with deparaffinizing agent xylene I at predetermined temperature for predetermined time for removing 70% of impurities;c. Contacting the biological bone samples of step(b) with deparaffinizing agent xylene II at predetermined temperature for predetermined time for removing remaining 30% of impurities;d. Contacting the biological bone samples of step(c) with deparaffinizing agent fresh xylene III at predetermined temperature for predetermined time for fixation and clarity of tissue in the said samples;e. Dipping the biological bone samples of step(d) with acetone for decolourization followed by washing in tap water for predetermined time;f. Staining the biological bone samples of step(e) with staining agent Haematoxylin for predetermined time for staining cytoplasm followed by washing in tap water for predetermined time;g. Dipping the biological bone samples of step(f) with 1% acid alcohol for removing excess Haematoxylin followed by washing in tap water for predetermined time ;h. Staining the biological bone samples of step(g) with staining agent Eosin for predetermined time for staining nucleus followed by washing in tap water for predetermined time;i. washing the biological bone samples of step(h) with 50% alcohol for removing water;j. washing the biological bone samples of step(i) with 70% alcohol for removing water;k. washing the biological bone samples of step(j) with 100% alcohol for removing water and l. drying the biological bone samples of step(k) and mounting to form stained biological sample with staining structures in cells.In another preferred embodiment, the present invention shall disclose a novel, cost effective hematoxylin and eosin staining process for staining biological bone samples comprising cells, employing characterized decalcyfication agent. The process of the present invention comprises of the following sequential steps:a. Characterized in that soaking the biological bone samples in vinegar at room temperature for 2 days for 70-80% removal of calciumb. Contacting the biological bone samples of step(a) with deparaffinizing agent xylene I and temperature maintained at 700C for 10 minutes for removing 70% of impurities;c. Contacting the biological bone samples of step(b) with deparaffinizing agent xylene II and temperature maintained at 700C for 10 minutes for removing remaining 30% of impurities;d. Contacting the biological bone samples of step(c) with deparaffinizing agent xylene III and temperature maintained at 700C for 10 minutes for fixation and clarity of tissue in the said samples;e. Dipping the biological bone samples of step(d) with acetone for decolourization followed by washing in tap water for 2 minutes;f. Staining the biological bone samples of step(e) with staining agent Haematoxylin for 10 minutes for staining cytoplasm followed by washing in tap water for 2 minutes;g. Dipping the biological bone samples of step(f) with 1% acid alcohol for removing excess Haematoxylin followed by washing in tap water for 5 minutes ;h. Staining the biological bone samples of step(g) with staining agent Eosin with 2 dip for staining nucleus followed by washing in tap water for 2 minutes;i. washing the biological bone samples of step(h) with 50% alcohol for removing water;j. washing the biological bone samples of step(i) with 70% alcohol for removing water;k. washing the biological bone samples of step(j) with 100% alcohol for removing water and l. drying the biological bone samples of step(k) and mounting to form stained biological bone sample with staining structures in cells.As per the invention, in the staining process, the vinegar is concentrated apple vinegar.In accordance with the invention, in the staining process, the orange fruit extract I, II and III are raw fresh extract squeezed from orange.Certain modifications and improvements will occur to those skilled in the art upon a reading of the foregoing description. The above-mentioned details are provided to serve the purpose of clarifying aspects of the invention and it will be apparent to one skilled in the art that they do not serve to limit the scope of the invention. All modifications and improvements have been deleted herein for the sake of conciseness and readability but are properly within the scope of the present invention. It is understood that the foregoing detailed description is given merely by way of illustration and that modification and variations may be made therein without departing from the spirit and scope of the invention.

Claims

Claims:WE CLAIM:

1. A novel, cost effective hematoxylin and eosin staining process for staining biological bone samples comprising cells, employing characterized decalcyfication agent, the claimed process comprises of the following sequential steps:a. Characterized in that soaking the said biological bone samples in vinegar at predetermined temperature for predetermined time for 70-80% removal of calciumb. Contacting the said biological bone samples of step(a) with deparaffinizing agent fresh Orange fruit extract I at predetermined temperature for predetermined time for removing 70% of impurities;c. Contacting the said biological bone samples of step(b) with deparaffinizing agent fresh Orange fruit extract II at predetermined temperature for predetermined time for removing remaining 30% of impurities;d. Contacting the said biological bone samples of step(c) with deparaffinizing agent fresh Orange fruit extract III at predetermined temperature for predetermined time for fixation and clarity of tissue in the said samples;e. Dipping the said biological bone samples of step(d) with acetone for decolourization followed by washing in tap water for predetermined time;f. Staining the said biological bone samples of step(e) with staining agent Haematoxylin for predetermined time for staining cytoplasm followed by washing in tap water for predetermined time;g. Dipping the said biological bone samples of step(f) with 1% acid alcohol for removing excess Haematoxylin followed by washing in tap water for predetermined time ;h. Staining the said biological bone samples of step(g) with staining agent Eosin for predetermined time for staining nucleus followed by washing in tap water for predetermined time;i. washing the said biological bone samples of step(h) with 50% alcohol for removing water;j. washing the said biological bone samples of step(i) with 70% alcohol for removing water;k. washing the said biological bone samples of step(j) with 100% alcohol for removing water and l. drying the said biological bone samples of step(k) and mounting to form stained biological sample with staining structures in cells.

2. A novel, cost effective hematoxylin and eosin staining process for staining biological bone samples comprising cells, employing characterized decalcyfication agent, the claimed process comprises of the following sequential steps:a. Characterized in that soaking the said biological bone samples in vinegar at room temperature for 2 days for 70-80% removal of calciumb. Contacting the said biological bone samples of step(a) with deparaffinizing agent fresh Orange fruit extract I and temperature maintained at 700C for 10 minutes for removing 70% of impurities;c. Contacting the said biological bone samples of step(b) with deparaffinizing agent fresh Orange fruit extract II and temperature maintained at 700C for 10 minutes for removing remaining 30% of impurities;d. Contacting the said biological bone samples of step(c) with deparaffinizing agent fresh Orange fruit extract III and temperature maintained at 700C for 10 minutes for fixation and clarity of tissue in the said samples;e. Dipping the said biological bone samples of step(d) with acetone for decolourization followed by washing in tap water for 2 minutes;f. Staining the said biological bone samples of step(e) with staining agent Haematoxylin for 10 minutes for staining cytoplasm followed by washing in tap water for 2 minutes;g. Dipping the said biological bone samples of step(f) with 1% acid alcohol for removing excess Haematoxylin followed by washing in tap water for 5 minutes ;h. Staining the said biological bone samples of step(g) with staining agent Eosin with 2 dip for staining nucleus followed by washing in tap water for 2 minutes;l. drying the said biological bone samples of step(k) and mounting to form stained biological bone sample with staining structures in cells.

3. The staining process as claimed in claim 1&2 wherein the said vinegar is concentrated apple vinegar.

4. The staining process as claimed in claim 1&2 wherein the said orange fruit extract I, II and III are raw fresh extract squeezed from orange.Dated this 07th day of Sep 2021For SREE BALAJI MEDICAL COLLEGE & HOSPITAL By its Patent AgentDr.B.Deepa , Description:Form 2THE PATENT ACT, 1970 (39 of 1970)THE PATENT RULES, 2003 COMPLETE SPECIFICATION(See section 10 and rule 13)“A NOVEL COST EFFECTIVE HEMATOXYLIN AND EOSIN STAINING PROCESS FOR STAINING BIOLOGICAL BONE”in the name of SREE BALAJI MEDICAL COLLEGE & HOSPITAL an Indian nationals having address at No 7, WORKS ROAD, CHENNAI-600 044, TAMIL NADU, INDIA,